Upstate Active Clinical Trials

Study Title:

A Phase III Randomized Trial of Adding Vincristine-topotecan-cyclophosphamide to Standard Chermotherapy in Initial Treatment of non-metastatic Ewing Sarcoma

What is the purpose of the study?

Randomized treatment study to look at combination chemotherapy in treating patients with non-metastatic extracranial Ewing sarcoma.

Upstate Institutional Review Board (IRB) Number:

253867

Study/Protocol ID:

AEWS1031

Study Phase:

III

Patient Age Group:

Children

Principal Investigator:

Karol H Kerr, MD

ClinicalTrials.Gov ID:

NCT01231906

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Beatriz Kovar
Phone: 315-464-7232
Email: kovarb@upstate.edu

Return to Previous Page || Search Again